Loading the records…
Loading the records…
Sen. Heinrich introduced S5783 to temporarily exempt buprenorphine from DEA's Suspicious Orders Report System for the remainder of the opioid public health emergency. The bill is in early stage, referred to Judiciary Committee. The narrow scope and temporary nature limit market impact.
The bill does not authorize spending or create new revenue streams. The primary effect is a reduction in regulatory burden for buprenorphine handlers. Given the opioid public health emergency's uncertain duration, the impact is limited. Indivior is the most exposed ticker, but the effect on its stock is likely negligible. No other major healthcare companies are significantly affected.
S5783, introduced by Sen. Martin Heinrich (D-NM) on November 19, 2026, would require the DEA Administrator to temporarily exempt buprenorphine from the Suspicious Orders Report System for the duration of the opioid public health emergency. The bill was read twice and referred to the Senate Committee on the Judiciary, indicating an early legislative stage with no cosponsors.
The bill does not authorize any funding; it is a regulatory relief measure. The Suspicious Orders Report System is a DEA mechanism to monitor controlled substance distribution. Exempting buprenorphine reduces reporting requirements for manufacturers, distributors, and pharmacies handling the drug. This could lower compliance costs and potentially improve access to buprenorphine for opioid use disorder treatment. However, the exemption is temporary, tied to the ongoing opioid public health emergency, which has been renewed since 2017.
The primary publicly traded company affected is Indivior, which manufactures Suboxone, the leading buprenorphine product. The reduced reporting burden may slightly ease distribution logistics, but the impact on Indivior's revenue is negligible given the temporary nature and the fact that compliance costs are a small fraction of overall expenses. Generic manufacturers like Teva ($TEVA) also produce buprenorphine but face even smaller relative impact.
Legislative path: The bill must pass the Judiciary Committee, then the full Senate, then the House, and be signed by the President. Given the early stage and lack of cosponsors, passage is uncertain. The opioid public health emergency's expiration could also render the exemption moot. Investors should view this as a low-impact, procedural bill with minimal market consequences.
Matched on shared policy language across AI analyses, with ticker & timing weight
To require the Administrator of the Drug Enforcement Administration to temporarily exempt buprenorphine from the Suspicious Orders Report System for the remainder of the opioid public health emergency.
MICHIGAN DEPARTMENT OF HEALTH AND HUMAN SERVICES: $111M Department of Health and Human Services Grant
MENTAL HEALTH & SUBSTANCE ABUSE SERVICES, TENNESSEE DEPARTMENT OF: $95.1M Department of Health and Human Services Grant
Executive orders & memoranda affecting the same sectors or companies
This executive order requires all federal contractors and subcontractors to notify the White House and relevant agencies of any congressional requests related to their work with the executive branch, and to follow instructions to withhold information deemed protected by executive privilege. It directs agencies to enforce these requirements through contract termination or debarment, and tasks the Office of Management and Budget with developing implementation guidance. The order aims to protect executive branch confidentiality and enhance efficiency in federal contracting by preventing uncoordinated disclosures to Congress.
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →